PLAU, plasminogen activator, urokinase, 5328

N. diseases: 439; N. variants: 8
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0087086
Disease: Thrombus
Thrombus
0.300 Therapeutic phenotype CTD_human [Preparation of thrombus-targeted urokinase liposomes and its thrombolytic effect in model rats]. 12830724 2003
CUI: C0087086
Disease: Thrombus
Thrombus
0.300 Therapeutic phenotype CTD_human Pulmonary emboli from pulse-spray and mechanical thrombolysis: evaluation with an animal dialysis-graft model. 8657906 1996
CUI: C0087086
Disease: Thrombus
Thrombus
0.300 Therapeutic phenotype CTD_human [Treatment of massive arterial thrombosis caused by thrombocytopenia induced by heparin with local thrombolysis]. 2106299 1990
CUI: C0087086
Disease: Thrombus
Thrombus
0.300 Therapeutic phenotype CTD_human Urokinase and AT-III concentrate treatment in inferior vena cava thrombosis associated with nephrotic syndrome. 2133253 1990
CUI: C0087086
Disease: Thrombus
Thrombus
0.300 Therapeutic phenotype CTD_human Intraoperative infusion of lytic drugs for thrombotic complications of revascularization. 2795766 1989
CUI: C0087086
Disease: Thrombus
Thrombus
0.300 Therapeutic phenotype CTD_human The urokinase-pulmonary embolism trial. 4884574 1969